David M. Angaran

495 total citations
27 papers, 339 citations indexed

About

David M. Angaran is a scholar working on Geriatrics and Gerontology, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, David M. Angaran has authored 27 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Geriatrics and Gerontology, 4 papers in Public Health, Environmental and Occupational Health and 4 papers in Pharmacology. Recurrent topics in David M. Angaran's work include Pharmaceutical Practices and Patient Outcomes (10 papers), Pharmacy and Medical Practices (4 papers) and Innovations in Medical Education (4 papers). David M. Angaran is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (10 papers), Pharmacy and Medical Practices (4 papers) and Innovations in Medical Education (4 papers). David M. Angaran collaborates with scholars based in United States and France. David M. Angaran's co-authors include Dustin D. French, Robert R. Campbell, Andrea M. Spehar, William F. Northrup, William G. Lindsay, Kit V. Arom, Demétre M. Nicoloff, Virgil C. Dias, Paul L. Doering and Joseph F. Dasta and has published in prestigious journals such as Annals of Surgery, Pharmaceutical Research and The Annals of Thoracic Surgery.

In The Last Decade

David M. Angaran

24 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David M. Angaran United States	11	98	61	59	49	43	27	339
R.P. Sequeira Bahrain	13	143 1.5×	47 0.8×	61 1.0×	58 1.2×	26 0.6×	26	347
Maria C. Pruchnicki United States	13	148 1.5×	100 1.6×	90 1.5×	56 1.1×	19 0.4×	32	383
Mario M. Zeolla United States	11	136 1.4×	90 1.5×	103 1.7×	84 1.7×	19 0.4×	17	362
Norma J. Owens United States	9	163 1.7×	89 1.5×	58 1.0×	27 0.6×	14 0.3×	16	390
Réjean Laprise Canada	8	166 1.7×	101 1.7×	71 1.2×	35 0.7×	24 0.6×	10	412
Max D. Ray United States	9	200 2.0×	117 1.9×	87 1.5×	27 0.6×	17 0.4×	31	330
Rohan Rasiah Australia	13	62 0.6×	101 1.7×	140 2.4×	54 1.1×	32 0.7×	31	381
Susan Paparella United States	13	138 1.4×	69 1.1×	51 0.9×	17 0.3×	54 1.3×	61	491
Johanna Ulfvarson Sweden	14	179 1.8×	37 0.6×	48 0.8×	44 0.9×	74 1.7×	29	498
Karen E. Bertch United States	7	155 1.6×	51 0.8×	69 1.2×	17 0.3×	37 0.9×	13	313

Countries citing papers authored by David M. Angaran

Since Specialization

Citations

This map shows the geographic impact of David M. Angaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Angaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Angaran more than expected).

Fields of papers citing papers by David M. Angaran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Angaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Angaran. The network helps show where David M. Angaran may publish in the future.

Co-authorship network of co-authors of David M. Angaran

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Angaran. A scholar is included among the top collaborators of David M. Angaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Angaran. David M. Angaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Segal, Richard, et al.. (2020). Opportunities and responsibilities for pharmacists to improve their effectiveness in addressing medication adherence through culturally sensitive collaborations with community health workers. Journal of the American Pharmacists Association. 60(4). e25–e30. 11 indexed citations

French, Dustin D., Robert R. Campbell, Andrea M. Spehar, & David M. Angaran. (2004). Benzodiazepines and injury: a risk adjusted model. Pharmacoepidemiology and Drug Safety. 14(1). 17–24. 28 indexed citations

Angaran, David M., et al.. (2000). Clinical Pharmacy: Looking 20 Years Back… Looking 20 Years Forward. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(10P2). 235S–242S. 3 indexed citations

Angaran, David M., et al.. (1999). Panel 4: Education and Skills Needed to Conduct, Interpret, and Use Economic Evaluations in Healthcare. Value in Health. 2(2). 88–91. 10 indexed citations

Angaran, David M.. (1991). Quality assurance to quality improvement: Measuring and monitoring pharmaceutical care. American Journal of Health-System Pharmacy. 48(9). 1901–1907. 18 indexed citations

Remmel, Rory P., et al.. (1991). The Effects Of Hemodilution, pH, and Protamine on Lidocaine Plasma Protein Binding and Red Blood-Cell Uptake in Vitro. Pharmaceutical Research. 8(1). 127–130. 7 indexed citations

Angaran, David M.. (1991). Selecting, Developing, and Evaluating Indicators. American Journal of Health-System Pharmacy. 48(9). 1931–1937. 25 indexed citations

Angaran, David M., et al.. (1990). Oxygen Homeostasis: Theory, Measurement, and Therapeutic Implications. DICP. 24(12). 1195–1203. 3 indexed citations

Angaran, David M.. (1989). Informed Consent: Ethical Issues and Future Challenges in Clinical Education.. American Journal of Pharmaceutical Education. 53(4). 9–12. 2 indexed citations

10.

Madsen, Joop, et al.. (1987). Comparison of diflunisal with acetaminophen plus codeine in posthemorrhoidectomy bowel function and analgesic efficacy. 42(2). 319–323. 1 indexed citations

11.

Ried, L. Douglas, et al.. (1986). What Patients Want to Know from Pharmacists: Suggestions for Pharmacy Education. American Journal of Pharmaceutical Education. 50(3). 235–239. 3 indexed citations

12.

Angaran, David M., et al.. (1986). Esmolol hydrochloride: An ultrashort-acting, β-adrenergic blocking agent. American Journal of Health-System Pharmacy. 43(5). 1322–1341. 28 indexed citations

13.

Angaran, David M., Virgil C. Dias, Kit V. Arom, et al.. (1984). The Influence of Prophylactic Antibiotics on the Warfarin Anticoagulation Response in the Postoperative Prosthetic Cardiac Valve Patient. Annals of Surgery. 199(1). 107–111. 16 indexed citations

14.

Dasta, Joseph F., et al.. (1984). Colloids Vs. Crystalloids—A Continuing Controversy. Drug Intelligence & Clinical Pharmacy. 18(3). 202–212. 14 indexed citations

15.

Arom, Kit V., David M. Angaran, William G. Lindsay, William F. Northrup, & Demétre M. Nicoloff. (1982). Effect of Sodium Nitroprusside during the Payback Period of Cardiopulmonary Bypass on the Incidence of Postoperative Arrhythmias. The Annals of Thoracic Surgery. 34(3). 307–312. 8 indexed citations

16.

Bond, Christopher & David M. Angaran. (1978). Simulated Clinical Testing for Clinical Pharmacy and Therapeutics Courses. American Journal of Pharmaceutical Education. 42(2). 126–129. 1 indexed citations

17.

Peterson, Charles D., et al.. (1977). Ticarcillin and Carbenicillin. Drug Intelligence & Clinical Pharmacy. 11(8). 482–486. 2 indexed citations

18.

Angaran, David M.. (1976). A Communication from Dr. Clinical: The Cynic Commission. Drug Intelligence & Clinical Pharmacy. 10(7). 394–395. 1 indexed citations

19.

Angaran, David M.. (1975). My Son, the Clinical Pharmacist. Drug Intelligence & Clinical Pharmacy. 9(6). 298–299.

20.

Angaran, David M.. (1975). A White Coat, Name Tag and Beeper. Drug Intelligence & Clinical Pharmacy. 9(10). 566–567.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact